Funding Opportunities

• The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional)
  (PAR-21-348)
  National Cancer Institute
  Application Receipt Date(s): December 15, 2023
  
  

• NINDS Institutional AD/ADRD Research Training Program (T32 Clinical Trial Not Allowed)
  (PAR-22-021)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Systems Biology for Infectious Diseases (U19 Clinical Trial Not Allowed)
  (RFA-AI-21-065)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): January 14, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date